92 related articles for article (PubMed ID: 2510987)
21. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
Chen G; Teicher BA; Frei E
Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
24. [Sensitivity of BALB/c and WR strain mice to the immunodepressive action of cyclophosphamide and thiophosphamide].
Ir KN; Telegin LIu; Pevnitskiĭ LA; Malashenko AM
Biull Eksp Biol Med; 1984 May; 97(5):598-600. PubMed ID: 6426547
[TBL] [Abstract][Full Text] [Related]
25. [Determination of individual sensitivity of ovarian tumors to alkylating agents].
Vinnitskaia VK; Kulik GI; Abragam KA; Oderiĭ-Korol' VI
Vopr Onkol; 1971; 17(7):27-31. PubMed ID: 5002943
[No Abstract] [Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
28. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
30. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
31. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
33. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Eder JP; Teicher BA; Holden SA; Cathcart KN; Schnipper LE; Frei E
Cancer Res; 1989 Feb; 49(3):595-8. PubMed ID: 2910481
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative evaluation of the efficacy of antineoplastic agents].
Karavainova MKh
Farmakol Toksikol; 1971; 34(5):618-21. PubMed ID: 5004886
[No Abstract] [Full Text] [Related]
35. Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor.
Longo FW; Tomashefsky P; Rivin BD; Tannenbaum M
Cancer Res; 1983 Jul; 43(7):3231-5. PubMed ID: 6406056
[TBL] [Abstract][Full Text] [Related]
36. NTP technical report on the toxicity studies of benzophenone (CAS No. 119-61-9). Administered in feed to F344/N rats and B6C3F mice.
Chhabra RS
Toxic Rep Ser; 2000 Apr; (61):1-53, A1-13. PubMed ID: 11803700
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
39. MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
Valeriote F; Grates H
J Natl Cancer Inst; 1986 Jan; 76(1):61-5. PubMed ID: 3455743
[TBL] [Abstract][Full Text] [Related]
40. The role of WR-2721 in radiotherapy and/or chemotherapy.
Yuhas JM; Spellman JM; Culo F
Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
